Literature DB >> 28522076

Sleep-wake stability in narcolepsy patients with normal, low and unmeasurable hypocretin levels.

Mathias Hvidtfelt Hansen1, Birgitte Rahbek Kornum2, Poul Jennum3.   

Abstract

OBJECTIVE: To compare diurnal and nocturnal electrophysiological data from narcolepsy patients with undetectable (<20 pg/mL), low (20-110 pg/mL) and normal (>110 pg/mL) cerebrospinal fluid (CSF) hypocretin-1 levels. PATIENTS/
METHODS: A total of 109 narcolepsy patients and 37 controls were studied; all had available CSF hypocretin-1 measurements. The sleep laboratory studies were conducted between 2008 and 2014. The study retrospectively examined measurements of sleep stage transitions in diurnal and nocturnal continuous polysomnography. The percentage distribution of time awake and rapid eye movement (REM) sleep, and the occurrence of sleep onset REM (SOREM) in the nocturnal polysomnography were also measured.
RESULTS: Participants with undetectable hypocretin-1 levels had significantly higher frequencies of transitions than controls and those with normal hypocretin-1 levels. Participants with low hypocretin-1 levels showed more transitions than controls and, in some cases, also more than those with normal hypocretin-1. Participants with normal hypocretin-1 failed to show any significant difference from the controls, except in the overall diurnal transitions.
CONCLUSION: Undetectable hypocretin-1 levels in particular, but also low hypocretin-1 levels, were associated with a less stable phenotype featuring more sleep state transitions and SOREM episodes. In addition, there was a distinction between nocturnal and diurnal REM sleep in hypocretin-deficient participants, expressed as increased diurnal REM sleep, which was not reflected in nocturnal sleep.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Hypocretin; Narcolepsy; Sleep transition

Mesh:

Substances:

Year:  2017        PMID: 28522076     DOI: 10.1016/j.sleep.2017.01.021

Source DB:  PubMed          Journal:  Sleep Med        ISSN: 1389-9457            Impact factor:   3.492


  4 in total

1.  Gut Microbiota in Patients with Type 1 Narcolepsy.

Authors:  Ruirui Zhang; Shanjun Gao; Shenghui Wang; Jiewen Zhang; Yingying Bai; Shuang He; Pan Zhao; Hongju Zhang
Journal:  Nat Sci Sleep       Date:  2021-11-06

Review 2.  The neurobiological basis of narcolepsy.

Authors:  Carrie E Mahoney; Andrew Cogswell; Igor J Koralnik; Thomas E Scammell
Journal:  Nat Rev Neurosci       Date:  2019-02       Impact factor: 34.870

3.  Stability of nocturnal wake and sleep stages defines central nervous system disorders of hypersomnolence.

Authors:  Kiran P Maski; Alicia Colclasure; Elaina Little; Erin Steinhart; Thomas E Scammell; William Navidi; Cecilia Diniz Behn
Journal:  Sleep       Date:  2021-07-09       Impact factor: 6.313

4.  Neural network analysis of sleep stages enables efficient diagnosis of narcolepsy.

Authors:  Jens B Stephansen; Alexander N Olesen; Mads Olsen; Aditya Ambati; Eileen B Leary; Hyatt E Moore; Oscar Carrillo; Ling Lin; Fang Han; Han Yan; Yun L Sun; Yves Dauvilliers; Sabine Scholz; Lucie Barateau; Birgit Hogl; Ambra Stefani; Seung Chul Hong; Tae Won Kim; Fabio Pizza; Giuseppe Plazzi; Stefano Vandi; Elena Antelmi; Dimitri Perrin; Samuel T Kuna; Paula K Schweitzer; Clete Kushida; Paul E Peppard; Helge B D Sorensen; Poul Jennum; Emmanuel Mignot
Journal:  Nat Commun       Date:  2018-12-06       Impact factor: 14.919

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.